"Relentless and dizzying rise of antimicrobial resistance"has contributed in a large measure to the persistence of infections as a major cause of morbidity and mortality.The purpose of this study was to catalog the carrier prevalence of MDR bacteria at the community level. It was mainly focused on isolating carriers from anterior nares and the gut and to determine their antimicrobial susceptibility pattern at admission. A total of 100 patients were screened for carriage prevalence of MDR bacteria in anterior nares and gut . Of the 158 isolates obtained from the stool samples, 48 (30.3%) were MDR, 34 (21.5%) were XDR and 3 (1.8%) were PDR. One more point worth noting was the pan-drug resistant organisms in the gut of 3 (03%) patients. 2 (66.6%) of these isolates were E.coli and the other was Enterococci. On the contrary, of 83 isolates obtained from nasal samples 18 (21.6%) were MDR and 7(8.43%) were XDR. (26.4%) of the Staphylococci obtained were multi-drug resistant. 20(29.4%) of the Staphylococci were MRSA. Of these 14 (70%) could be CA-MRSA. 33 (24.6%) and 30(22.3%) of the GNBs obtained from the stool samples were ESBL and MBL producers respectively.Thirteen (54.1%) of the isolates of Enterococci were multi-drug resistant. 10 (41.6%) of the Enterococci were resistant to vancomycin. In this situation, it is perhaps better for all the health care institutions to come up with their own screening strategy, in order to the curb the evolution of these multi-drug resistant bacteria to a destructive rate.
Bacterial antimicrobial drug resistance is a worldwide problem that is exacerbated by the diminishing number of new antimicrobial drugs in the pharmaceutical pipeline 1 . Recent concern has lead to plethora of govt. and agency reports advocating less antibacterial use, better infection control and development of new antibacterials 2 . The rapid emergence of resistance to antibiotics amongst pathogens generates visions of the 'potential post-antibiotic era threatening present and future medical advances'. Overall burden of bacterial infection is rising, largely fuelled by antimicrobial resistant organisms 3 . Certain areas in hospitals like ICUs and areas with immunocompromised and debilitated patients as well as treatment modalities like topical and prophylactic use of antibiotics are foci of generation of multidrug resistant (MDR) bacteria. Gradual dissemination to the community through population interactions spreads the organism widely. 4 This spread represents the convergence of various factors including mutations, development of selection pressure in hospitals and in the community and inability of some laboratory testing methods to detect emerging resistant phenotypes. 5,6.7 . Expanded use of antimicrobial agents in hospitals and outside the hospital increases the selective pressure for these organisms 8 .
The correlation between invitro resistance and treatment failure is imperfect, but resistance undoubtedly increases mortality, morbidity and costs in many settings 2 . While newer drugs have kept the problem under control, the poorer communities are squeezed between the rampant resistance and inadequate resources. Thus the contribution of infectious disease to overall mortality is greater in impoverished societies. 3 Thus it is very much necessary to track the misuse of antibiotics. MDR strains not only complicate anti-infective therapy, but it also heightens the need for effective control policies to prevent the spread of MDR organisms to other hospitalized patients.9,10Screening for MDR organisms is one of the many approaches needed to deal with the very major clinical problem concerning drug resistance.
A sensitive, specific and cost effective screening test may help the clinicians in the choice of appropriate antimicrobial therapy, provide baseline data about the epidemiology of MDR pathogen, to guide policy recommendations and help in infection control by early identification of patients, thereby facilitating an informed decision about infection control interventions.
These interventions may include notification to the concerned clinical and nursing team, infection control precautions such as isolation or cohort nursing of such patients, use of decolonization regimens, use of antibacterial prophylaxis during surgery or other invasive interventions of use of an appropriate agent for empirical antibiotic therapy in case of unconfirmed infection in a colonized patient 11 . This approach is wise as suggested by Berkelmen and colleagues, who wrote, "history has shown us repeatedly, in terms of both human suffering and economic loss, that the cost of preparedness through vigilance are far more lower than those needed to respond to unanticipated public health crises" 12 . Also in the Indian scenario, there is a very low coverage of surveillance, poor data management, lack of intersectoral co-operation. With this background, this study was taken up to know the carriage prevalence of multi-drug resistant bacteria and to emphasize on the burden of antimicrobial resistance in the society.
MATERIALS AND METHODS
The present observational study was carried out in the Department ofMicrobiology, Mysore Medical College and Research Institute, Mysore and its attached hospitals during 2013.
Inclusion criteria
Patients at admission without any past history of long hospital stay or any other hospital admissions.
Exclusion criteria
Patients should not be a health worker, should not have any history of immunocompromised status.
Sample collection
2 nasal swabs and 1 stool sample were collected from each patient. Nasal swabs were taken from anterior nares with a sterile cotton swab. Stool samples were collected in the sterile universal container. Total transit time to the laboratory was within 30 minutes. Samples were processed as per the standard protocols 13 .
Nasal samples
Microscopy and culture of nasal swabs was performed. Erythromycin andclindamycin disk were placed at a distance of 21mm to identify D-zone indicating the development of inducible resistance.15
Stool samples
Stool microscopy was done and samples were cultured and the isolates were identified by standard biochemical reactions.14AST was performed for each isolated bacteria. Ampicillin-10 mcg, tetracycline-30 mcg, gentamicin-10 mcg, ciprofloxacin-5 mcg, ceftazidime-30 mcg, ceftazidime/clavulanic acid-30/10 mcg, cotrimoxazole-23.75 mcg and meropenem-10 mcg disks were used to test the susceptibility in the gram-negative bacteria(GNB). A zone diameter of < 16mm around the meropenem disk was presumed to be as MBL-producing organism. A > 5mm increase in zone diameter for ceftazidime in combination with clavulanic acid-30/10 mcg versus ceftazidime10mcg zone tested alone is taken as ( ESBLproducing organism.15To test the susceptibility pattern among the Enterococci, penicillin-10 units, erythromycin-15 mcg, clindamycin2mcg, ciprofloxacin-5 mcg, ceftriaxone-30 mcg, vancomycin-30 mcg, linezolid-30 mcg, gentamicin-10 mcg, chloramphenicol-30 mcg cotrimoxazole -23.75 mcg disks were used.
RESULTS
A total of 100 patients were screened at admission or/ within 48 hours of admission.
The age of the population studied ranged between 16-88 years. The mean age was 52 years. 100 nasal swabs yielded 83 isolates. Of these, 56 patients were monobacterial carriers and 15 patients were polybacterial carriers. 29 samples yielded no growth. Most commonly isolated bacteria from the anterior nares were MS-CoNS (33.7%), followed by MRSA (20.4%) and MSSA (15.6%). 100 stool samples yielded 158 isolates. 54 patients were monobacterial carriers and the rest of 46 were polybacterial carriers.The isolates resistant to 3 or > 3 categories of antimicrobials used for testing antimicrobial susceptibility pattern in GNBs were considered as MDR. Those resistant to all the categories except 1 or 2 categories were considered as XDR and those resistant to all the drugs in all the 6 categories of antimicrobials were 
DISCUSSION
Survival of the fittest holds good for the men as well as the bacteria. Some of the nonpathogenic bacteria in nature live as commensals in our body. A limited population of bacteria, which have become pathogenic, were also sensitive to antibiotics to start with. It is the man made antibiotic pressure, which has led to the emergence and spread of resistant genes among the bacteria. In the present study randomly100 patients at admission or within 48 hours of admission were screened for various drug resistance patterns. Nasal samples yielded 35 (42.16%) of CoNS& 33 (39.75%) of Staphylococcus aureus. 25 (30.1%) isolates obtained from the anterior nares were found to be multi-drug resistant. The prevalence of MRSA was 60.60% & MR-CoNS was 20% in our study. Among 20 isolates of MRSA, 14 isolates that amounts to 70% strains were considered to be CA-MRSA as they were commonly sensitive to most categories of antibiotics except few.
In a study by S.Saxena et al,16in 2002, of the 317 nasal swabs from healthy individuals in the community, 94 (29.6%) yielded growth of Staphylococcus aureusand 17 (18%) of them were MRSA strains. In another observational study by K.E. Vandana,17nine (4.28%) nasal swabs from patients 210 collected at the time of admission grew MRSA.
Initially MRSA strains were associated with nosocomial infections, but later they were disseminated into the community. The development of methicillin resistance among Staphylococcus aureusin the community may be due to horizontal acquisition of mecA gene from the hospital settings. Also health care workers are important reservoirs for transfer of these resistant bacteria through anterior nares .It is very difficult to know the extent of spread of resistant bacteria at the community level except by surveillance studies. However, whether acquired nosocomially or through community, these strains go unrecognized unless the clinical infection develops. This high carriage of multi drug resistant organisms in nares is definitive risk factor for further cross infections & treatment at the hospital level.
In our study, a total of 33 (24.6%) ESBL producers & 30(22.30%) isolates of MBL producers were obtained. Also among 14 patients <60years , four (28.5%) patients were ESBL producers & six (42.8%) patients were found to colonize with MBL producers in their gut. Among the nasal gram negative isolates isolated, 1(6.66%) isolate was an MBL producer.
A study by A.A. Kader and K.A. Kamath 18 , regarding the fecal carriage of ESBL producing bacteria in a community in Saudi Arabia isolated 91 (12.7%) of ESBL producers from 716 faecal specimens of which 85 (95.6%) were E. coli and 4 (4.4%) were Klebsiella pneumonia. In comparison to the study by K.E. Vandana17, where 21 (18.58%) ESBL producers were isolated from 113 stool samples, in our study 33 (33%) ESBL producers were obtained from 100 stool samples.
Prevalence of these drug resistance patterns is the point of discussion everywhere. Antibiotic use creates a selective pressure on the host bacteria in the large bowel which leads to the emergence of antimicrobial resistant organisms, which in turn increases the number of carriers and enhances the opportunity for these bacteria to cause infections. Without knowing the susceptibility pattern, these resistant bacteria are very difficult to treat, causing treatment failures. Many laboratories fail to detect these resistant patterns.Clinicians should have proper knowledge about the ESBL and MBL producers for choosing better alternatives to avoid unnecessary empirical treatment.
Older age is always a risk factor for any complications. Probably patient compliance with drugs, frequent exposure to antibiotics, cross infections, complications like diabetes mellitus etc can be few reasons for higher levels of MDR bacteria in older age groups.
In our study we isolated 24 Enterococci from 100 faecal specimens, of which 10 (41.64%) were found to be vancomycin resistant. These findings mirrors those of a study by I. Klare et al,19who isolated 12 (12%) faecalglycopeptides resistant (van A type) Enterococcus faeciumfrom 100 non hospitalized patients and 5 (38.4%) van A type E. faeciumfrom 13 samples of raw minced meat of pigs from different butcher shops. But in contrast to the study by K.E.Vandana 17 , where 3 (6.25%) VRE were obtained from 113 stool samples, in our study the VRE (24%) isolates obtained were higher.
Enterococci are normal constituents of the gut flora of humans and majority of the animals. Despite the high standards of hygiene during the slaughtering process, contamination of the meat and the meat products by the intestinal flora of the slaughtered animals cannot be excluded. Furthermore, the use of antibiotics as feed additives for growth enhancement in animals may be associated with the emergence of VRE. Enterococci can reach human consumers via the food chain. However it remains to be elucidated whether VRE of the probable animal sources takes a short passage through the human intestine after food consumption or if they become permanent residents.
Another classical example of emergence of resistance due to abuse of antibiotics is the extensive use of vancomycin. As the infections due to MRSA in hospitals all over the world increased, vancomycin became the drug of the choice to treat these infections. This led to the selection of VRE present as normal flora in the gut of the patient and possibly contributed to the emergence of VRE besides other factors.
One more point worth noting was the pandrug resistant organisms in the gut of three patients. Two of these isolates were E.coliand the other was Enterococci. This may be due to extensive exposure of the gut to the antibiotics rather than the anterior nares or the breathing airways.
Various contributing factors other than these included likethe combination of poverty and ignorance making the ground perfect for the development of resistance. Community awareness of the issues involved in antibiotic therapy is poor and this is compounded by over the counter drug availability & self-medication .The commonly used drugs are generally inexpensive and popular broadspectrum agents. Patient's pressure, aggressive marketing by pharmaceutical company, lack of uniformity among physicians to follow antibiotic policy, inadequate intake causing the recurrence of the disease also have added to this practice.
Gene events that cause sensitive bacteria to become resistant could be intrinsic like point mutations or extrinsic like horizontal transfer of resistant genes between the bacteria by the dissemination of transposons, integrons, plasmids, that give rise to so called gene epidemics. The reasons for this epidemic success of bacteria may be due to increased adherence to host cells, greater tolerance to disinfectants and desiccation, faster growth rates, lack of hygiene in hospitals and disregard to isolation precautions in most of the busy hospitals with limited resources. Also, community acquired resistant strains on admission to hospitals exchange genetic information with nosocomial isolates resulting in 'superbugs' that could cause difficult-to-treat infections.
Antibiotics are widely used in agriculture and aquaculture for therapeutic, prophylactic and growth promoting purposes. Antibiotics in flesh of such animals may enter the human intestine via food chain. Antimicrobial resistant bacteria can also be found on fruits and vegetables due to the spreading of sewage sludge on farmland and direct use of antibiotics on the fruits. Presence of antimicrobial resistant bacteria has also been reported in the fresh water sources. The antibacterial substances added to diverse household cleaning are similar to antibiotics in many ways 20 . Release of fabric conditioning chemicals into a reed bed system has recently shown tostrongly select for Class I integron carriage, which is a key molecular mechanism for the spread of antibiotic resistant genes by horizontal transfer 21 . The situation is alarming. This emerging threat has to be tackled at the initial phase itself, which could be done through active surveillance of antimicrobial resistance in the community.
In essence, some strategies also aim in optimizing the antibiotic stress in the environment, using decolonization regimens for those harboring resistant bacteria, rotating antibiotics, decrease unintended interaction between antibiotics and pathogens, restrict the spread of resistant organisms and treat infections with minimum amount of antibiotics necessary to effect the cure. Education of professionals and public, accessibility of the microbiological investigation and its results to the general practitioner in an effort to rationalize the choice of antimicrobial therapy, regulatory issues with central prescribing restrictions and advertising restrictions, closer international co-operation is also required to combat this problem. Equally important is the co-ordination of surveillance of antibiotic resistance in human and animal health sector along with regulating antibiotic use in both sectors, restriction of antibiotic use as growth promoters in animals.
For all this to be successful, the initiative lies in screening the patients at an early stage. Epidemiological surveillance of antimicrobial resistance, is indispensible for empirically treating infections, implementing resistance control measures and preventing spread of antimicrobial organisms in the healthy community.
CONCLUSION
A screen-isolate-destroy strategy is very effective for the control of MDR.Information to the doctors regarding drug susceptibility through routine screening of the patients before admission would be an effort to rationalize the judicious use of antibiotics and to implement the antibiotic policy. Continuously updated data through epidemiological surveillance on antimicrobial resistance will continue to be essential to ensure effective infection control & patient care.
